- Home
- STRO vs BNY Comparison
STRO vs BNY Comparison
Compare STRO & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- BNY
- Stock Information
- Founded
- STRO 2003
- BNY 2001
- Country
- STRO United States
- BNY United States
- Employees
- STRO N/A
- BNY N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- BNY Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- BNY Finance
- Exchange
- STRO Nasdaq
- BNY Nasdaq
- Market Cap
- STRO 77.7M
- BNY 233.2M
- IPO Year
- STRO 2018
- BNY N/A
- Fundamental
- Price
- STRO $0.76
- BNY $9.60
- Analyst Decision
- STRO Hold
- BNY
- Analyst Count
- STRO 7
- BNY 0
- Target Price
- STRO $3.97
- BNY N/A
- AVG Volume (30 Days)
- STRO 1.2M
- BNY 52.7K
- Earning Date
- STRO 08-12-2025
- BNY 01-01-0001
- Dividend Yield
- STRO N/A
- BNY 3.93%
- EPS Growth
- STRO N/A
- BNY N/A
- EPS
- STRO N/A
- BNY N/A
- Revenue
- STRO $66,434,000.00
- BNY N/A
- Revenue This Year
- STRO N/A
- BNY N/A
- Revenue Next Year
- STRO N/A
- BNY N/A
- P/E Ratio
- STRO N/A
- BNY N/A
- Revenue Growth
- STRO N/A
- BNY N/A
- 52 Week Low
- STRO $0.52
- BNY $8.60
- 52 Week High
- STRO $5.17
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- STRO 49.28
- BNY 43.10
- Support Level
- STRO $0.73
- BNY $9.59
- Resistance Level
- STRO $0.83
- BNY $9.71
- Average True Range (ATR)
- STRO 0.06
- BNY 0.07
- MACD
- STRO 0.01
- BNY 0.00
- Stochastic Oscillator
- STRO 61.90
- BNY 6.25
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.